IQ heads into its Thursday earnings report with short sellers adding pressure and borrow conditions tightening — a combination that makes the lending market worth watching closely.
Short interest has climbed steadily all month. At 7.6% of the free float, it has risen roughly 5% over the past 30 days and now ranks in the first percentile of the ORTEX universe on short score rank — meaning nearly every comparable stock carries less short pressure. The ORTEX short score has crept up to 79.97, its highest reading in the available window, consolidating in a tight range between 78.6 and 80.0 across the past two weeks. That persistence signals systematic bearish conviction rather than a single tactical position. Borrow availability has tightened sharply over the same period, dropping from above 130% in mid-July to 56% now — still not in distress territory, but the direction is unambiguous. Cost to borrow remains low at 0.74%, though it has risen 8% on the week and 15% over the month, reflecting incrementally greater demand for borrowed shares ahead of the event.
Price action reinforces the cautious read. The stock fell 7.5% on Tuesday alone to close at $1.23, extending a weekly loss of nearly 9%. That one-day drop is notable in the context of IQ's only comparable recent earnings reaction: after the May 2026 print, the stock fell 4.3% on the day and slid a further 5.2% over the following five sessions. Options positioning is not flashing alarm — the put/call ratio at 0.98 sits fractionally below its 20-day average of 0.99, with a z-score near zero, suggesting the options market is not pricing in directional drama beyond what is already in the price.
The bull and bear debate on IQ has been running for well over a year without resolution. The bear argument is structural: persistent losses, negative free cash flow, and a stock now trading well below book value at a price-to-book of 0.66. The bull argument rests largely on valuation compression and earnings estimate momentum, which ranks in the 96th percentile on both 30-day and 90-day EPS momentum and on EPS surprise — an unusually strong fundamental signal for a stock under this much short pressure. The analyst data worth noting is stale: the most recent substantive coverage dates to August 2025, when UBS upgraded to Buy with a $3.32 target and Jefferies raised its Buy target to $2.50. At a current price of $1.23, both targets imply substantial upside on paper, but given how much time has passed, those figures carry limited weight in the current setup. Baidu controls 45% of shares, keeping the freely tradable float structurally constrained.
Thursday's print will test whether the improving EPS momentum signal translates into hard numbers — and whether the bear case built on persistent cash burn holds or begins to crack at these price levels.
See the live data behind this article on ORTEX.
Open IQ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
